| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A Distinct Region in Erythropoietin that Induces Immuno/Inflammatory Modulation and Tissue Protection
|
Yuan, RuiRong
|
|
2015
|
12 |
4 |
p. 850-861
|
article
|
| 2 |
A Distinct Region in Erythropoietin that Induces Immuno/Inflammatory Modulation and Tissue Protection
|
Yuan, RuiRong
|
|
|
12 |
4 |
p. 850-861
|
article
|
| 3 |
An Overview of Products and Bias in Research
|
Gloss, David
|
|
2015
|
12 |
4 |
p. 731-734
|
article
|
| 4 |
An Overview of Products and Bias in Research
|
Gloss, David
|
|
|
12 |
4 |
p. 731-734
|
article
|
| 5 |
Cannabidiol as a Potential Treatment for Anxiety Disorders
|
Blessing, Esther M.
|
|
2015
|
12 |
4 |
p. 825-836
|
article
|
| 6 |
Cannabidiol as a Potential Treatment for Anxiety Disorders
|
Blessing, Esther M.
|
|
|
12 |
4 |
p. 825-836
|
article
|
| 7 |
Cannabinoids and Epilepsy
|
Rosenberg, Evan C.
|
|
2015
|
12 |
4 |
p. 747-768
|
article
|
| 8 |
Cannabinoids and Epilepsy
|
Rosenberg, Evan C.
|
|
|
12 |
4 |
p. 747-768
|
article
|
| 9 |
Cannabinoids and Schizophrenia: Risks and Therapeutic Potential
|
Manseau, Marc W.
|
|
2015
|
12 |
4 |
p. 816-824
|
article
|
| 10 |
Cannabinoids and Schizophrenia: Risks and Therapeutic Potential
|
Manseau, Marc W.
|
|
|
12 |
4 |
p. 816-824
|
article
|
| 11 |
Cannabinoids and Tremor Induced by Motor-related Disorders: Friend or Foe?
|
Arjmand, Shokouh
|
|
2015
|
12 |
4 |
p. 778-787
|
article
|
| 12 |
Cannabinoids and Tremor Induced by Motor-related Disorders: Friend or Foe?
|
Arjmand, Shokouh
|
|
|
12 |
4 |
p. 778-787
|
article
|
| 13 |
Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications
|
Fernández-Ruiz, Javier
|
|
2015
|
12 |
4 |
p. 793-806
|
article
|
| 14 |
Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications
|
Fernández-Ruiz, Javier
|
|
|
12 |
4 |
p. 793-806
|
article
|
| 15 |
Cannabinoids in the Treatment of Neurological Disorders
|
Devinsky, Orrin
|
|
2015
|
12 |
4 |
p. 689-691
|
article
|
| 16 |
Cannabinoids in the Treatment of Neurological Disorders
|
Devinsky, Orrin
|
|
|
12 |
4 |
p. 689-691
|
article
|
| 17 |
Cannabis in the Treatment of Dystonia, Dyskinesias, and Tics
|
Koppel, Barbara S.
|
|
2015
|
12 |
4 |
p. 788-792
|
article
|
| 18 |
Cannabis in the Treatment of Dystonia, Dyskinesias, and Tics
|
Koppel, Barbara S.
|
|
|
12 |
4 |
p. 788-792
|
article
|
| 19 |
Clinical Use of Cannabinoids for Symptom Control in Multiple Sclerosis
|
Notcutt, William G.
|
|
2015
|
12 |
4 |
p. 769-777
|
article
|
| 20 |
Clinical Use of Cannabinoids for Symptom Control in Multiple Sclerosis
|
Notcutt, William G.
|
|
|
12 |
4 |
p. 769-777
|
article
|
| 21 |
Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage
|
Hurd, Yasmin L.
|
|
2015
|
12 |
4 |
p. 807-815
|
article
|
| 22 |
Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage
|
Hurd, Yasmin L.
|
|
|
12 |
4 |
p. 807-815
|
article
|
| 23 |
Effect of Readthrough Treatment in Fibroblasts of Patients Affected by Lysosomal Diseases Caused by Premature Termination Codons
|
Matalonga, Leslie
|
|
2015
|
12 |
4 |
p. 874-886
|
article
|
| 24 |
Effect of Readthrough Treatment in Fibroblasts of Patients Affected by Lysosomal Diseases Caused by Premature Termination Codons
|
Matalonga, Leslie
|
|
|
12 |
4 |
p. 874-886
|
article
|
| 25 |
Endocannabinoid Signaling in Autism
|
Chakrabarti, Bhismadev
|
|
2015
|
12 |
4 |
p. 837-847
|
article
|
| 26 |
Endocannabinoid Signaling in Autism
|
Chakrabarti, Bhismadev
|
|
|
12 |
4 |
p. 837-847
|
article
|
| 27 |
Enduring Elevations of Hippocampal Amyloid Precursor Protein and Iron Are Features of β-Amyloid Toxicity and Are Mediated by Tau
|
Li, Xuling
|
|
2015
|
12 |
4 |
p. 862-873
|
article
|
| 28 |
Enduring Elevations of Hippocampal Amyloid Precursor Protein and Iron Are Features of β-Amyloid Toxicity and Are Mediated by Tau
|
Li, Xuling
|
|
|
12 |
4 |
p. 862-873
|
article
|
| 29 |
Erratum to: Cannabinoids in the Treatment of Neurological Disorders
|
Devinsky, Orrin
|
|
2015
|
12 |
4 |
p. 910
|
article
|
| 30 |
Erratum to: Cannabinoids in the Treatment of Neurological Disorders
|
Devinsky, Orrin
|
|
|
12 |
4 |
p. 910
|
article
|
| 31 |
Erratum to: Parsing Physiological Functions of Erythropoietin One Domain at a Time
|
Steinman, Lawrence
|
|
2015
|
12 |
4 |
p. 911
|
article
|
| 32 |
Erratum to: Parsing Physiological Functions of Erythropoietin One Domain at a Time
|
Steinman, Lawrence
|
|
|
12 |
4 |
p. 911
|
article
|
| 33 |
Molecular Targets of Cannabidiol in Neurological Disorders
|
Ibeas Bih, Clementino
|
|
2015
|
12 |
4 |
p. 699-730
|
article
|
| 34 |
Molecular Targets of Cannabidiol in Neurological Disorders
|
Ibeas Bih, Clementino
|
|
|
12 |
4 |
p. 699-730
|
article
|
| 35 |
Neuroinflammation: Ways in Which the Immune System Affects the Brain
|
Ransohoff, Richard M.
|
|
2015
|
12 |
4 |
p. 896-909
|
article
|
| 36 |
Neuroinflammation: Ways in Which the Immune System Affects the Brain
|
Ransohoff, Richard M.
|
|
|
12 |
4 |
p. 896-909
|
article
|
| 37 |
Parsing Physiological Functions of Erythropoietin One Domain at a Time
|
Steinman, Lawrence
|
|
2015
|
12 |
4 |
p. 848-849
|
article
|
| 38 |
Parsing Physiological Functions of Erythropoietin One Domain at a Time
|
Steinman, Lawrence
|
|
|
12 |
4 |
p. 848-849
|
article
|
| 39 |
Safety and Toxicology of Cannabinoids
|
Sachs, Jane
|
|
2015
|
12 |
4 |
p. 735-746
|
article
|
| 40 |
Safety and Toxicology of Cannabinoids
|
Sachs, Jane
|
|
|
12 |
4 |
p. 735-746
|
article
|
| 41 |
The Endocannabinoid System and its Modulation by Phytocannabinoids
|
Di Marzo, Vincenzo
|
|
2015
|
12 |
4 |
p. 692-698
|
article
|
| 42 |
The Endocannabinoid System and its Modulation by Phytocannabinoids
|
Di Marzo, Vincenzo
|
|
|
12 |
4 |
p. 692-698
|
article
|
| 43 |
Triple Therapy with Prednisolone, Pegylated Interferon and Sodium Valproate Improves Clinical Outcome and Reduces Human T-Cell Leukemia Virus Type 1 (HTLV-1) Proviral Load, Tax and HBZ mRNA Expression in Patients with HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
|
Boostani, Reza
|
|
2015
|
12 |
4 |
p. 887-895
|
article
|
| 44 |
Triple Therapy with Prednisolone, Pegylated Interferon and Sodium Valproate Improves Clinical Outcome and Reduces Human T-Cell Leukemia Virus Type 1 (HTLV-1) Proviral Load, Tax and HBZ mRNA Expression in Patients with HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
|
Boostani, Reza
|
|
|
12 |
4 |
p. 887-895
|
article
|
Journal description